NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/25/2025
Back to search
Official data from USPTO
ACUREX BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACUREX BIOSCIENCES
ST13
US500000090981351Class
42
Filing
90981351
Registration
7706735
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
06/12/2026
Trademark type
Word
Nice classes
42
Filing date
12/21/2020
Registration date
02/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2025
Last transaction
06/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-04-00
First use in commerce
2023-04-00
Drawing code
4
Owner type
03
Owner location
SAN CARLOS, CA, US
Examiner
SABAGH, LAILA TAREK
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
A. C. (pessoa física)
A. C. (pessoa física)
Representatives
KAREN WON MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development services in the fields of neurologicalcentral nervous systemmitochondrialmetabolic diseases and disordersParkinson's DiseaseAlzheimer'sALSHuntington'sdiseases of aging; providing medical and scientific research and information in the fields of neurologicalcentral nervous systemmitochondrialmetabolic diseases and disordersParkinson's DiseaseAlzheimer'sALSHuntington'sdiseases of aging; medical diagnostic research and pharmaceutical development services for drug discovery in the fields of neurologicalcentral nervous systemmitochondrialmetabolic diseases and disordersParkinson'sAlzheimer'sALSHuntington'sdiseases of aging
Publications
History of USPTO decisions and trademark events.
45 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/01/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/18/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/17/2025
EX3G
SOU EXTENSION 3 GRANTED
01/17/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
01/17/2025
CORV
REVIEW OF CORRESPONDENCE COMPLETE
01/17/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/10/2024
IUAF
USE AMENDMENT FILED
09/30/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/30/2024
EXT3
SOU EXTENSION 3 FILED
09/29/2024
DRRR
DIVISIONAL REQUEST RECEIVED
09/29/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/29/2024
EISU
TEAS STATEMENT OF USE RECEIVED
09/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
09/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/14/2024
EX2G
SOU EXTENSION 2 GRANTED
03/13/2024
EXT2
SOU EXTENSION 2 FILED
03/13/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/13/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/19/2023
EX1G
SOU EXTENSION 1 GRANTED
07/17/2023
EXT1
SOU EXTENSION 1 FILED
07/17/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/17/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/28/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/15/2023
TMBN
TTAB RELEASE CASE TO TRADEMARKS
02/13/2023
OP.T
OPPOSITION TERMINATED NO. 999999
02/13/2023
OP.D
OPPOSITION DISMISSED NO. 999999
02/13/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
04/21/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/23/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/26/2021
PUBO
PUBLISHED FOR OPPOSITION
10/26/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2021
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
06/19/2021
GPRA
PRIORITY ACTION E-MAILED
06/19/2021
CPRA
PRIORITY ACTION WRITTEN
06/19/2021
DOCK
ASSIGNED TO EXAMINER
06/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/04/2021
NWAP
NEW APPLICATION ENTERED
12/24/2020
Continuous trademark protection
Get notified about every new filing that threatens ACUREX BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.